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Skin is known to be one of the worst affected target organs in graft-versus-host
disease (GVHD)' (1). The cutaneous lesions are characterized by the epidermal cell
death in association with a prominent T cell infiltrate (2). It is therefore thought
that the cutaneous lesions occur as the result ofa T cell-mediated immune attack
on epidermal cells, either directly or via the release of various cytokines from the
Tcells, although the problem ofwhether the T cells toward the epidermal antigens
causethese lesions hasbeen still unclear (3). Whilemuch attention hasbeen directed
to effector T cells capable ofmediating GVHD, almost nothing is known about the
mechanism(s) by whichthe integrity oforgan structures canbe protected from such
a T cell-mediated immune attack in GVHD. This is due, in part, to a difficulty
in producing experimental models ofGVHD to be able to investigate theprotection
mechanism(s).
We have recently demonstrated that cutaneous GVHD, resembling lichen planus
andlupus erythematosusin humans, can beinduced in normal mice by intradermal
inoculation into the footpads of cloned, autoreactive CD4+ T cells with cytolytic
activity (4-6). Theexperimentally inducedcutaneous GVHD isbasically composed
oftwotypes ofreactions: delayed-typehypersensitivity(DTH)reactions and epidermal
cell damage defined histologically. DTH responses measurable by footpad swelling
peaks at 24-48 h and then gradually recedes (5). Histologically, the DTH responses
are characterized bythediffuseinfiltration ofmononuclearcells andprominentedema
in the dermis . In contrast, epidermal lesions characterized by the severe infiltration
of T cells associated with the consequent epidermal cell damage reach maximum
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severity at 4 and 5 d (5). The lesions, however, subside rapidly and the epidermis
returns to normal by 14 d (6). Such rapid recovery from the experimentally induced
cutaneous GVHD suggested to us that suppression mechanisms could play a role
in recovering the epidermal integrity from the destruction and in protecting it from
an additional attack by T cells. To investigate this possibility, the present study asks
the following questions. (a) Are those mice that spontaneously recovered from the
experimentally induced cutaneous GVHD resistant to subsequent attempts to in-
duce the cutaneous GVHD? and (b) if so, which cells are responsible for the resis-
tance to cutaneous GVHD?
Our results indicate that those mice recovered from the experimentally induced
cutaneous GVHD acquire long-term resistance to the cutaneous GVHD. This re-
sistance was not due to the generation of antiidiotypic T cells. Unexpectedly, this
long-term, local resistance to cutaneous GVHD was accompanied by a nearly 30-
fold increase in the number of Thy-1 + epidermal cells (Thy-1+ EC). Although Thy-
1 + EC bearing TCR.y/b have recently been the focus of intense research interest,
evidence for the physiologic role in situ is still lacking (7, 8). In this paper we provide
for the first time evidence indicating that Thy-1' EC play an important role in pro-
tecting the epidermal integrity from a T cell-mediated immune attack.
Materials and Methods
Mice.
￿
Female C57BL/6 (B6) mice were obtained from Charles RiverJapan, Inc., Atsugi,
Kanagawa, and female B10.Thy-1 .1 mice were bred in our laboratories. They were used pre-
dominantly at 8-12 wks old.
Cloned T Cell Lines.
￿
General characteristics of the cloned T cell lines used are shown in
Table I. The derivation and maintenance of the T cell lines have been described in detail
previously (4, 9-11). BB5, SKI, and J403 cells are capable of migrating into the epidermis
upon their intradermal inoculation into the footpads of the syngeneic (in case of BB5) or
appropriate allogeneic recipients with I-Ak.b,t.r (in case of SKI) or with H-2K6 (in case of
J403) and cause the destruction of the epidermis, histologic changes identical to those seen
in human cutaneous GVHD(4, 5). In contrast, other cloned T cells are completely incapable
of migrating into the epidermis: they are unable to induce cutaneous GVHD even when
injected into the footpads of appropriate recipients with relevant antigens (4, 5).
Assayfor DTH Responses.
￿
As described previously (5), these cloned T cells were harvested
from culture 7-10 d after antigenic stimulation. Before the T cells were used in experiments,
dead cells in the preparation were removed on a lymphocyte separation media (Sigma Chem-
ical Co., St. Louis, MO) density gradient. After being washed with HBSS three times, re-
maining cells with >97% viability were injected intradermally, in a volume of 25 tt,l, into
hind footpads of recipient mice. The resultant swelling of the footpads was measured with
TABLE I
Description of T Cell Clones
" LN, lymph node.
1 Uncloned cell line .
Clone Source
Strain of
origin
Antigen
specificity Function
Ability to produce
cutaneous GVHD
13135 LN" 136 I-Ab (self) Cytotoxic/helper + + +
C10 Spleen 136 I-Ab (self) Cytotoxic/helper -
82F12 LN" B6 CGG + I-Ab Helper -
SKI Spleen A.TH I-Ak.b,r.r Cytotoxic/helper + +
J4031 Spleen B10.BR H-2Kb Cytotoxic + ti + +SHIOHARA ET AL.
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a dial thickness gauge at several time points after injection of the T cells. The results are
expressed as the arithmetic mean of measurements obtained from six mice.
Assayfor Cutaneous GVHD.
￿
Footpad skin biopsies taken from mice at several time points
after the injection of the T cells were fixed in 3.7% buffered formaldehyde and were em-
bedded in paraffin. Sections 2,um thick were stained with hematoxylin and eosin. The cuta-
neous GVHD was evaluated both semiquantitatively by the intensity of epidermal invasion
ofthe injected T cells and the severity of epidermal cell damage, as previously described (6).
The semiquantitative evaluation ofepidermal invasion by the injected T cells was performed
by counting lymphoid cells within the epidermis, because our previous immunohistochem-
ical studies showed that 72 h after the injection of the T cells intraepidermal lymphoid cells
are mainly composed ofthe injected T cells, with small numbers of recruited T cells of host
origin (4). At least30 serial sections were examined for each individual footpad, and ofthese,
six sections in which the epidermis was regarded to be most heavily infiltrated with lymphoid
cells were enumerated. The results were expressed as the number oflymphoid cells per linear
millimeter of epidermis that was calculated from that within the totalepidermal length sur-
veyed. The severity ofthe epidermal cell damage was scored according to the grading system
described by Lerner et al. (12) for cutaneous GVHD. This evaluation was performed in a
blind fashion by two investigators who were not informed of the treatment.
Antibody Reagents.
￿
The mAbs we used were antiThy-1.2 (rat IgG 2b; Becton Dickinson
& Co., Mountain View, CA), antiThy-1.1 (mouse IgG 2b; Meiji Laboratories, Tokyo, Japan),
anti-I-A b.k (mouse IgG 2a; Meiji), anti-CD3e chain (145-2C11; hamster IgG), anti-CD4
(GK1 .5; rat IgG 26), anti-CD8 (anti-Lyt-2.2; mouse IgG 2a; Meiji) and anti-asialo GM,
(rabbit IgG).
Immuno.fluorescence Staining.
￿
Epidermal sheets from the footpads were separated from the
dermis by incubation in 0.02% EDTA for 2 h at 37 °C as described (5). The sheets fixed
in acetone for 10 min were extensively washed in PBS and incubated with appropriate dilu-
tions of first-step antibodies for 16 h at 4°C. Then they were washed in PBS for 1 h and
incubated for 1 h at 37°C with appropriate second-step antibodies labeled with FITC: FITC-
F(ab')2-goat anti-mouse IgG, FITC-F(ab')2-goat anti-rat IgG, FITC-F(ab'~-goat anti-rabbit
IgG (Tago Inc., Burlingame, CA) and FITC-F(ab)2-goat anti-hamster IgG (Cappel Labora-
tories, Cochranville, PA). For anti-I-A/antiThy-1.2 double labeling, the sheets were incubated
with biotinylated anti-I-A b.k (Meiji Laboratories) at 1 :20, followed by Texas Red-labeled
avidin (Tago Inc.) at 1 :400 and FITC-antiThy-1.2 (Becton Dickinson Inc.). The stained spec-
imens were mounted in glycerin PBS and viewed through a fluorescence microscope.
Statistical Analysis.
￿
The statistical significance of the differences between different groups
of mice was determined using Student's t-test; t6 < 0.05 (two-tailed test) was considered
significant.
Results
InductionofResistance to Cutaneous GVHD.
￿
To determine whether those mice that
spontaneously recovered from the experimentally induced cutaneous GVHD would
be resistant to subsequent attempts to induce the cutaneous GVHD, 2 x 106 au-
toreactive cloned T cells capable ofproducing cutaneous GVHD, termed BB5, were
injected into the same footpad sites of syngeneic (B6) mice that had received 2 x
106 BB5 cells 2 wk before. While untreated mice were highly susceptible to the ac-
tive induction of the cutaneous GVHD (Fig. 1 A), those mice that had spontane-
ously recovered from the cutaneous GVHD failed to develop the cutaneous GVHD
defined by the epidermal invasion of the T cells and epidermal cell damage (Fig.
1 B): those mice had normal appearing epidermis with little or no intraepidermal
lymphoid cells, although in the dermis there was a marked lymphoid infiltration
indistinguishable from that observed in the untreated mice. Thus, the footpads of
mice that had recovered from the cutaneous GVHD appeared to become resistant
to the active reinduction ofthe cutaneous GVHD. However, pretreatment with 2 x1030
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FIGURE 1 .
￿
Cutaneous GVHD lesions in the footpads of B6 mice at 4 d after intradermal injec-
tion of 2 x 10 6 BB5 cells . The footpad skin of the control mouse (A) shows the destruction of
epidermal structures associated with an extensive infiltrate of lymphocytes ; in contrast, in the
footpad skin of the mouse pretreated with 2 x 106 BB5 cells 2 wk before (B), no epidermal cell
degeneration can be seen, although the infiltrative pattern in the dermis is similar to that shown
in A . Hematoxylin and eosin, x66 .00
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106 BB5 cells did not affect the ability of the mice to mount DTH reactions by sub-
sequent injection of 2 x 106 13135 cells. Fig. 2 illustrates the typical time course of
the development of the DTH reactions and cutaneous GVHD in those mice. In ad-
dition, with regard to the ability to exhibit the GVH reactions manifested by the
enlargement of popliteal lymphnodes (PLN) after intradermal injection of BB5 cells,
no significant differences were noted between untreated mice and those pretreated
with 13115 cells 2 wk before (data not shown). As shown in Table II, mice whose
right footpads had been injected with BB5 cells 2 wk before no longer developed
the cutaneous GVHD, provided that 13135 cells were injected into the right footpads,
while the untreated left footpads of the same mice remained susceptible to the active
induction of the cutaneous GVHD by 13135 cells. These results suggest that resis-
TABLE II
Untreated Sites of Mice Injected with T Cell Clone Are Not Resistant to
Subsequent Attempts to Induce Cutaneous GVHD
' On day 0, 2 x 106 13135 cells were injected into the same footpad sites (right side) that had received 2
x 106 13135 cells 2 wk before.
t On day 0, 2 x 106 13135 cells were injected into the untreated footpad sites (left side) whose right footpads
had received 2 x 106 BB5 cells 2 wk before.
s On day 0, 2 x
￿
106 13135 cells were injected into the untreated footpad sites of normal control mice.
h p < 0.001 compared with control mouse.
T cell clone injected
on day - 14 to cause
GVHD resistance
Footpad site of
injection of
13135 cells on day 0
No. of lymphoid cells
invading the epidermis
on day 4
No.
0
of mice
GVHD
+ 1
with
lesions
(grade)
+ 2
cutaneous
on day
+ 3
4
+ 4
BB5 Injected site* 14 ± 511 6 0 0 0 0
Untreated sites 96 ± 36 0 1 3 2 0
(injected mouse)
Untreated sites I11 t 30 0 0 3 3 0
(control mouse)1032
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tance to cutaneous GVHD is restricted to the injection sites and that locally acting,
downregulatory mechanisms could be involved in the resistance.
Specificity and Persistence ofResistance.
￿
We next examined whether the local resis-
tance was specific for the T cell clone used for the induction ofthe resistance. Var-
ious T cell clones capable or incapable ofproducing cutaneous GVHD were tested
for their ability to induce local resistance to the cutaneous GVHD in B6 mice. As
shown in Table 111, inoculation ofcutaneous GVHD-producing T cell clones, such
as SKI andJ403, also was able to induce local resistance to the subsequent induc-
tion ofcutaneous GVHD by either SKI orBB5. In contrast, resistance to the cuta-
neous GVHD was never induced by pretreatment with other cutaneous GVHD-
nonproducing Tcell clones, suchasC10 and82F12, evenwhen used at supraoptimal
doses (5 x 106-107 cells/footpad). These results indicate that the local resistance in-
duced was not clonotypic.
To determine whether the destruction of epidermal structures by T cell clones
is prerequisite for the induction of the resistance, suboptimal doses of either BB5
ofSKI cells that had been shown not to produce significant cutaneous GVHD le-
sions were injected and 2 wk later 2 x 106 13135 cells were again injected into the
same footpads. Table IV shows that the footpads of B6 mice pretreated with either
BB5 or SKI cells acquired resistance to the cutaneous GVHD in a dose-dependent
manner: complete resistance was seen, when 2 x 106 BB5 cells were injected 2 wk
before, while twofold more SKI cells were required to achieve the same effect. The
resistance induced by low doses of BB5 (<0.5 x 106) or SKI cells (51 x 106) was
not so complete as that induced by 2 x 106 11135 cells and was able to be partially
overcome with the active induction by high doses of 13135 cells (;4 x 106). The
ability ofthese T cells to induce the resistance appeared to be proportional to their
ability to induce the destruction of epidermal structures.
Further experiments were conducted to determine the persistence of the local re-
TABLE III
Specificity of Resistance to Cutaneous GVHD Caused by Injection with T Cell Clone
No. of mice with
cutaneous GVHD
On day - 14, 2 x 106 T cell clones indicated were injected into the footpads of B6 mice to induce the
resistance to cutaneous GVHD.
$ On day 0, 2 x 106 BB5 or SKI cells were again injected into the same footpad sites.
9 p < 0.0005 compared with control mice without pretreatment.
T cell clone injected
on day - 14 to cause
GVHD resistance`
Injection of
T cell clone
on day Ot
Footpad increase
on day 2
(10-2 Turn ± SD)
No. of lymphoid cells
invading the epidermis
on day 4 0
lesions on day 4
(grade)
+1 +2 +3 +4
None B115 53 .7 ± 4.4 128 1 20 0 0 2 4 0
BB5 BB5 57 .1 1 2 .9 7 ± 69 6 0 0 0 0
CIO BB5 55.2 ± 5.1 121 ± 23 0 0 3 3 0
82F12 BB5 56.3 1 4.6 114 1 32 0 1 2 3 0
SKI BB5 58.5 ± 2.9 24 ± 229 5 1 0 0 0
J403 13115 57 .0 ± 2 .2 9 ± 39 3 0 0 0 0
None SKI 38.5 1 7.0 98 } 29 0 1 3 2 0
SKI SKI 42.7 1 4.2 21 t 149 5 1 0 0 0
CIO SKI 41 .3 f 5 .6 106 1 24 0 1 1 4 0
B135 SKI 39.8 1 6.6 14 ± 69 6 0 0 0 0SHIOHARA ET AL.
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TABLE IV
Dose Dependence of Induction of Resistance to Cutaneous GVHD Caused by Injection of T Cell Clone
" p < 0.05 compared with control mice without pretreatment.
1 p < 0.0001 compared with control mice without pretreatment .
sistance. At various lengths oftime after receiving 2 x 106 BB5 cells or C10 cells,
B6 mice were injected intradermally with 2 x 106 BB5 cells. By up to 8 mo the
epidermis of footpads pretreated with BB5 cells never again became susceptible to
destruction by BB5 cells, provided that the BB5 cells were injected into the same
footpads that had received BB5 cells on day 0 (Table V). In ongoing experiments,
we found that 1 yr after the first injection with BB5 cells, the complete resistance
wasstill observed. Thus, long-termlocal resistance tothe cutaneous GVHD demon-
strated here may represent locally acting suppression mechanisms, rather than a
result ofgeneration ofantiidiotypic responses that can specificallysuppressthe func-
tion of effector T cells.
TABLE V
Persistence of Resistance to Cutaneous GVHD Caused by Injection of T Cell Clone
At various lengths of time indicated after first injection of 2 x 106 BB5 or C 10 cells, 2 x 106 BB5 cells
were again injected into the same footpad sites.
1 p < 0.0001 compared with control mice without pretreatment.
T cell clone injected
on day - 14 to cause
GVHD resistance
Injection of
T cell clone
on day 0
No. of lymphoid cells
invading the epidermis
on day 4
No. of mice with cutaneous
GVHD lesions on day 4
0 + 1 + 2 + 3
(Grade)
+ 4
None 2 x 106 BB5 138 + 17 0 0 1 3 0
0.1 x 106 BB5 2 x 106 BB5 82 f 27` 0 2 0 2 0
0.5 x 106 BB5 2 x 106 BB5 92 + 32 0 1 2 1 0
1 x 106 BB5 2 x 106 BB5 37 + 91 3 1 0 0 0
2 x 106 BB5 2 x 106 BB5 16 ± 91 4 0 0 0 0
0 .5 x 106 SKI 2 x 106 B135 95 ± 37 1 0 1 2 0
1 x 106 SKI 2 x 106 BB5 62 + 42 2 1 0 1 0
2 x 106 SKI 2 x 106 BB5 44 + 21" 2 2 0 0 0
4 x 106 SKI 2 x 106 BB5 17 + 5" 4 0 0 0 0
First
T cell clone
GVHD
Weeks after
injection"
injection of
to cause
resistance
Injected
T cell clone
Injection of
T cell clone
on day 0
No. of lymphoid cells
invading the epidermis
on day 4
No. of mice with cutaneous
GVHD lesions on day 4 (grade)
0 + 1 + 2 + 3 + 4
4 BB5 BB5 19 1 51 5 0 0 0 0
CIO BB5 140 1 25 0 0 1 4 0
None BB5 131 1 31 0 0 1 3 0
8 BB5 BB5 25 1 111 4 1 0 0 0
CIO BB5 125 1 26 0 0 2 3 0
None BB5 125 28 0 0 2 3 0
16 BB5 BB5 16 1 61 4 0 0 0 0
None BB5 115 f 22 0 0 2 2 0
32 BB5 BB5 20 1 41 4 0 0 0 0
None BB5 136 1 34 0 0 1 3 01034
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Lesional Epidermis Contains Large Numbers of Thy-1' EC.
￿
These results prompted
us to investigate whether the resistance was due to a loss ofsome epidermal cell popu-
lations necessary for epidermal invasion of the T cells or if there was the appearance
or the incresae in numbers ofepidermal cell populations able to protect the integrity
ofepidermis from an additional attack by the T cells . The preparation ofepidermal
sheets obtained from footpads either before or after the injection of.2 x 106 BB5
cells wereexamined by the immunofluorescence technique . Our earlier studies indi-
cated that Thy-1' EC present in footpad epidermis are different from those in other
sites, such as ear and body wall skin, with respect to their distribution and mor-
phology : the former Thy-1' EC occur predominantly at peripheral, hair-bearing
areas, but rarely at central, non-hair-bearing areas, while the latter cells are evenly
distributed ; and the former cells, particularly those at central, non-hair-bearing areas,
are angular and less dendritic, while the latter cells are predominantly dendritic.
By contrast, there were no site variations in the densities of I-A' Langerhans cells.
As described above, the epidermis rapidly recovered from the destruction induced
by the T cells and 14-21 d after the injection of the T cells no histologically detect-
able lesions were observed in the epidermis (Fig . 3) : as far as hematoxylin eosin
staining sections were concerned, the histologic findings of the epidermis were in-
distinguishable from that before injection of the T cells . The normal appearing
epidermis, however, contained a large number of Thy-1' EC (Fig . 4 A) : The
number of Thy-1' EC/mm2 was 20-30-fold higher in the epidermis of the footpads
that had received 2 x 106 BB5 cells 2 wk before than that in untreated footpads
(Fig . 4 B) . In addition, the majority of the Thy-1' EC observed in the former
FIGURE 3 .
￿
Histology of the footpad skin of 136 mice that received 2 x 10 6 13135 cells 2 wk be-
fore and that recovered from the destruction . Hematoxylin and eosin, x66.SHIOHARA ET AL .
FIGURE 4 .
￿
Immunolluorescence ofThy-1.2` EC in epidermal sheets from B6 murine footpad .
(A)At 2 wk after injection of 2 x 106 BB5 cells, the footpad epidermis contains a large number
of Thy-1 ` EC despite normal appearance of the histologic finding . (B) The footpad epidermis
of normal mouse is relatively deficient in Thy-1' EC . x80 .
10351036
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FIGURE 5.
￿
The densities of Thy-
1' EC (O) and I-A' Langerhans
ce11s (") in the footpad epidermis
ofB6 mice followinginjection of2 x
106 BB5 cells. A closed arrow in-
dicates the injection ofBB5 cells on
day 0. Each point represents the
mean t SE derived from six to
seven mice. During the develop-
ment of the cutaneous GVHD, it
was almost impossible to quantita-
tively assess the absolute numbers
of positively stainedcells due to the
intense nonspecific staining as a re-
sult of the extensive destruction of
epidermal structures. The recovery
o
￿
from the destruction 2 wk after in-
jection ofBB5 cellsmade it possible
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epidermis, unlike their normal counterparts observed in ear orbodywall skin, were
primarily angular andonly<5% ofthemappeared dendritic in morphology. In some
areas, theywere observed to form small clusters. Double-stainingexperiments indi-
cated that >70% ofthe Thy-1' EC were positive for CD3, although not so intensely
as those located in hair-bearing areas. Like the normal counterparts, they lacked
I-A, CD4, and CD8 expression. Anti-asialo GM1 stained a portion of the Thy-1'
EC strongly. The increase in Thy-1+ EC numberwas never observed in the footpads
that had received T cell clones incapable of producing cutaneous GVHD, as was
the resistance. In the footpads ofB10.Thy-1 .1 mice thathad received BB5 cells (Thy-
1.2') 21 d before, Thy-1.1+ cells were found in increased numbers, while Thy-1.2'
cells were never observed (data not shown). It was therefore obvious that the in-
creased Thy-1' EC are exclusively of recipient origin and the injected T cells are
eradicated from the epidermis 21 d after the injection. Thus, it is unlikely that the
injected Tcells remaining in the epidermis are directly involved in the resistance
to cutaneous GVHD.
Interestingly, the great increase in the number of Thy-1' EC following the de-
struction of epidermal structures in the cutaneous GVHD was accompanied by a
profound decrease in Langerhans cell number. The number of Langerhans cells,
however, recovered gradually and returned to the normal levels by 8 wk after the
injection, as shown in Fig. 5. In contrast, the marked increase in number of Thy-
1' EC persisted for at least 8 mo, although its extent declined slowly over several
months. These changes in the numbers of Thy-1' EC and Langerhans cells were
confined to the injected site: in other sites, such as another untreated footpad and
ear, these changes were not observed, when examined 2 wk after the injection of
BB5 cells (data not shown). Taken together, major differences between "resistant"
and "susceptible" epidermis are found at the density of Thy-1' EC of host origin.
Discussion
Recent studies with experimental models of organ-specific autoimmune disease
(13-16) have suggested the existence ofdownregulatory mechanism(s) by which theSHIOHARA ET AL.
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integrity oforgan structures can be protected from aTcell-mediated autoimmune
attack. Several hypothesis have been put forward to explain the protection mecha-
nism(s). In some models, generation ofantiidiotypic T cellsthat can inhibit the au-
toimmune effector Tcells hasbeenthought tobe one ofsuch mechanism(s) (13-15).
An entirely different mechanism that has been offered is that organ-resident, non-
lymphoid cellsmay suppress proliferation ofautoimmuneT cells, therebyrepresenting
an important component of a locally acting suppression mechanism against auto-
immune Tcells (16). The concept ofthe locally acting suppression mechanisms ex-
plains the ability of organ-resident cells to participate in protecting the integrity of
organ structures without involving antiidiotypic suppressor T cells.
In this study we have demonstrated that long-term local resistance to cutaneous
GVHD can be induced in mice by the intradermal injection ofthe cloned T cells
capable ofproducing cutaneous GVHD but not ofthose incapable ofit. The acqui-
sition of resistance to cutaneous GVHD demonstrated here was confined to the
epidermal structures, because the intradermal injection ofthe T cells did not affect
the susceptibility ofmice to subsequent active induction ofDTH responses andGVH
reactions manifested by the enlargement ofthe PLN. Thus far, resistance to GVH
reactions has been extensively studied by the use of the PLN weight assay (17, 18),
both because the enlargement of the lymph nodes that drain the site of injection
was believed torepresent alocal GVH reaction and because ofits readyavailability.
The PLN weight assay, however, may not necessarily be suitable for the detection
of resistance to GVHD, because it has been suggested that in some experimental
systems the state oftolerance could be manifested by the enlargement oflymphoid
organs due to the extensive activation ofall lymphocyte subsets (19). Resistance to
DTH reactions has also been studied in some experimental systems: Perez et al.
have demonstrated that mice thathad received alloreactiveTcells photoinactivated
with the chemical crosslinker 8-methoxypsoralen (8-MOP) and UV A light failed
to mount a DTH reaction to the alloantigen used for the vaccination, but not to
other alloantigens (20).
Because DTH responses are thought to reflect the proliferation oflymphocytes,
release ofvarious cytokines, and recruitment ofhost cells, this method also can not
be free from the drawbacks of the PLN weight assay. Although skin is one of the
most severely affected organs in GVHD and the histopathological effects of cuta-
neous GVHD have been evaluated by the severity ofepidermal cell damage, little
attention has thus far been given to the epidermal lesions in experiments showing
resistance to GVH reaction. Thus, one must realize that most of the information
available on the resistance to GVH reactions has been derived from experiments
usingthe PLN weight assay and DTH responses. In thisstudy, the cutaneous GVHD
was evaluated by the microscopic observations ofthe epidermal lesions in addition
to the two conventional methods, PLN weight assay and DTH reactions. In fact,
the resistance to cutaneous GVHD in mice pretreated with the T cells capable of
producing cutaneous GVHD was demonstrated only by the microscopic observa-
tions ofthe epidermal lesions, but not by the two conventional methods. Our data
did not provide any evidence indicating the generation ofantiidiotypic suppressor
T cells in resistant mice, which have been demonstrated as one ofthe main mecha-
nisms ofresistance in other experimental models (13-15), but instead demonstrated
the existence ofanepidermis-resident protection mechanism, which has never been1038
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described . The choice of assay systems may have caused other investigators to miss
such an epidermis-resident protection mechanism not involving suppressorT cells
as demonstrated here .
The reason is not clear yet why only epidermal structures, but not dermal struc-
tures, can be protected from aT cell-mediated immune attack in the resistant mice,
while in naive mice epidermal structures are relatively susceptible to destruction
by the T cells as compared with dermal structures . Which subpopulation(s) in
epidermis can serve to protect the integrity of epidermis from a subsequent attack
by theT cells? The present results show that the footpads of mice that became resis-
tant to subsequent inductionofthecutaneousGVHD contained unexpectedly large
numbers of Thy-1 + EC in the epidermis . The numbers of the Thy-1 ` EC in the
resistant mice were 20-30-fold higher than those in normal controls . Such a great
increase in the Thy-1' EC number persisted for at least 8 mo, during which time
complete resistance was seen . In addition, the increase was observed only in the in-
jected sites, but not in the untreated sites of-the same mice, which remained totally
susceptible to the active induction of the cutaneousGVHD (Table 11) . Thus, resis-
tance to the cutaneous GVHD as measured by the protection of epidermal struc-
tures from a subsequentT cell attack appears to closely correlate with the great in-
crease in Thy-1' EC numbers.
Is there any possibility that epidermal cell populations other than Thy-1 + EC are
involved in the induction ofthe resistance? We have previously reported that epidermal
invasion of the GVHD-producingTcellswas accompanied by la expression on ker-
atinocytes (4, 5) . Therefore, in view of previous suggestions by Gaspari et al . that
Ia' keratinocytes may induce antigen-specific unresponsiveness in T cells (21), it
is possible that Ia' keratinocytes could provide a defense mechanism against a T
cell attack by inactivating and helping to eliminate the aggressorT cells. However,
there are some strong arguments against acausal relationship between the presence
of Ia{ keratinocytes and the induction of the resistance : la expression on keratino-
cytes induced by theTcells was transient and no longer evident 2 wk afterinjection
of the T cells, at which time the epidermal structures were protected from the T
cell attack ; althoughTcells incapable ofproducingcutaneousGVHD, e.g ., C10 cells,
can also induce la expression by keratinocytes upon the intradermal injection, they
were unable to induce the resistance, as demonstrated in Table III . Thus, although
la' keratinocytes may be playing some role in the spontaneous resolution of the cu-
taneous GVHD lesions induced by theT cells, it is unlikely that clonal anergy of
the T cells by la' keratinocytes represents a major mechanism for the resistance
demonstrated here .
In line with previous observations that Thy-1 ` EC bearingTCR-'y/b are the main
lymphocyte population residing in epidermis (22) and that these TCR--Y/b cellshave
non- MHC-restricted cytotoxic function (23), the notion has been suggested, but
not yet proved, that Thy-1' EC are able to recognize a novel antigen expressed by
infected, transformed, ordamaged keratinocytes and express cytotoxic activity, thereby
protecting the integrity of epidermis (24) . Ourresults provideexperimental support
for the proposed role of Thy-l' EC as a protection mechanism for the epidermal
integrity . Thepresent observations that the resistance to the cutaneousGVHD was
not clonotypic and that there is a good correlation between the intensity of the de-
struction of epidermal structures induced by theT cells for the induction of resis-SHIOHARA FT A1 . .
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tanceand the degree of the resistance induced are in accordance with the hypothesis
that Thy-1+ EC may recognize a novel, common antigen expressed by damaged ker-
atinocytes, but not conventional class I and II MHC molecules (24) .
However, it should also be pointed out that the mere presence of high numbers
of Thy-I + EC in epidermis is not sufficient to render the epidermis resistant to a
T cell-mediated attack, since ear and body wall epidermis in naive mice contains
high numbers of Thy-1+ EC comparable to those in footpad epidermis 12 wk after
injection of the T cells, but it is susceptible to destruction by the T cells (data not
shown) . There are at least two possible explanations for this discrepancy : one pos-
sible explanation is that extensive activation by damaged keratinocytes during the
development of cutaneous GVHD would be required for Thy-1 ` EC residing in the
epidermis to become functional . Consistent with this notion is our findings'that
the local resistance induced by the T cells was not clonotypic and that the ability
of the T cells to induce the resistance paralleled the ability to induce the destruction
of epidermal structures upon intradermal injection . Another possibility is that the
Thy-1 + EC that are found in increased numbers in the footpad epidermis of mice
recovering from the cutaneous GVHD may represent a separate T lymphocyte lin-
eage from Thy-1 + EC originally residing in normal murine epidermis . Indeed, our
preliminary staining analysis with the use ofantiTCRy/S (3A10) andTCRat//3 (H57-
597) mAbs indicates that a large number of the Thy-1+ EC found in "resistant"
epidermis seem to be TCR-y/b+, while a small portion of the Thy-1+ EC reacted
with antiTCR-ot//3 (Shiohara, T, N . Moriya, C . Gotoh, and M . Nagashima, un-
published data) . In addition, our preliminary data using another set of anti-CD8
mAbs show that many if not all of the Thy-1 + EC expressed very low levels ofCD8 .
Given CD8 expression in the Thy-1 + EC population, it is reasonable to speculate
that the Thy-1 + EC presumably involved in the resistance resemble intestinal in-
traepithelial lymphocytes (IEL) (25), a subset ofy/S T cells resident in the gut, rather
than Thy-1+ EC originally residing in the epidermis . Because TCR gene usage is
shown to be different in bothT cell populations (26, 27), further investigations are
certainly needed to identify TCR-y/S gene usage of the Thy-1 + EC . Thus, studies
to determine whether the Thy-I + EC could exhibit a limited diversity of'I'CR-y/S
gene usage as do otherT cells will provide important information about the hetero-
geneity of y/S TCR .
Understanding the cellular and molecular basis of the resistance to cutaneous
GVHD will provide further insight into the protection mechanisms lot- epidermal
integrity and provide alternative therapeutic approaches to cutaneous GVHD and
otherT cell-mediated skin diseases .
Summary
The cutaneous graft-versus-host disease (GVHD) lesions induced by intradermal
injection of cloned autoreactive "I' cells have been shown to subside rapidly and the
epidermis returns to normal 2 wk after injection . Those mice that had spontane-
ously recovered from the cutaneousGVHDbecame resistant to subsequent attempts
to induce the cutaneous GVHD by the T cells while maintaining their activity to
mount delayed-type hypersensitivity (IDTH) responses and to induce the enlarge-
ment of the popliteal lymph nodes (PI.N) . The resistance appeared to be restricted
to the epidermal structures of the injection sites, suggesting the involvement of lo-1040
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cally acting suppression mechanisms. This local resistance was not specific for the
clonotype used for the induction of the resistance. A loss of the epidermal integrity
by an attack of T cells capable of producing cutaneous GVHD was a prerequisite
for the induction of the resistance. By up to at least 8 mo after injection of the T
cells, no mice became susceptible to the cutaneous GVHD again, provided that the
T cells were injected into the same footpad sites that had initially received the T
cells. This resistance correlated well with the great increase (20-30-fold) in Thy-1+
EC number. The great increase in the number of Thy-1 + EC following destruction
of epidermal structures may be important in protecting the epidermal integrity from
an additional attack by T cells.
Receivedfor publication 22 August 1989 and in revisedform 19 December 1989.
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